Telemonitoring, Telemedicine and Time in Range During the Pandemic: Paradigm Change for Diabetes Risk Management in the Post-COVID Future.
Thomas Danne,Catarina Limbert,Manel Puig Domingo,Stefano Del Prato,Eric Renard,Pratik Choudhary,Pratik Choudhary,Alexander Seibold +7 more
Reads0
Chats0
TLDR
In this article, the impact of the COVID-19 pandemic on the use of telemonitoring in the acute hospitalized setting as well as during daily diabetes management is discussed.Abstract:
People with diabetes are at greater risk for negative outcomes from COVID-19. Though this risk is multifactorial, poor glycaemic control before and during admission to hospital for COVID-19 is likely to contribute to the increased risk. The COVID-19 pandemic and restrictions on mobility and interaction can also be expected to impact on daily glucose management of people with diabetes. Telemonitoring of glucose metrics has been widely used during the pandemic in people with diabetes, including adults and children with T1D, allowing an exploration of the impact of COVID-19 inside and outside the hospital setting on glycaemic control. To date, 27 studies including 69,294 individuals with T1D have reported the effect of glycaemic control during the COVID-19 pandemic. Despite restricted access to diabetes clinics, glycaemic control has not deteriorated for 25/27 cohorts and improved in 23/27 study groups. Significantly, time in range (TIR) 70-180 mg/dL (3.9-10 mmol/L) increased across 19/27 cohorts with a median 3.3% (- 6.0% to 11.2%) change. Thirty per cent of the cohorts with TIR data reported an average clinically significant TIR improvement of 5% or more, possibly as a consequence of more accurate glucose monitoring and improved connectivity through telemedicine. Periodic consultations using telemedicine enables care of people with diabetes while limiting the need for in-person attendance at diabetes clinics. Reports that sustained hyperglycaemia and early-stage diabetic ketoacidosis may go untreated because of the lockdown and concerns about potential exposure to the risk of infection argue for wider access to glucose telemonitoring. Therefore, in this paper we have critically reviewed reports concerning use of telemonitoring in the acute hospitalized setting as well as during daily diabetes management. Furthermore, we discuss the indications and implications of adopting telemonitoring and telemedicine in the present challenging time, as well as their potential for the future.read more
Citations
More filters
Journal ArticleDOI
Glycaemic control during the lockdown for COVID-19 in adults with type 1 diabetes: A meta-analysis of observational studies.
Monia Garofolo,Michele Aragona,Cosimo Rodia,Pierpaolo Falcetta,Alessandra Bertolotto,Fabrizio Campi,Stefano Del Prato,Giuseppe Penno +7 more
TL;DR: In this paper, the effects of lockdown due to COVID-19 pandemic on glucose metrics, measured by glucose monitoring systems, in adult individuals with type 1 diabetes were assessed using a systematic literature search for English language articles from MEDLINE, Scopus and Web of Science up to February 28, 2021.
Journal ArticleDOI
Diabetes and the COVID-19 pandemic
TL;DR: In this paper , the authors summarized the impact of acute COVID-19 in people with diabetes and discussed how the presentation and epidemiology during the pandemic, including presentation of diabetic ketoacidosis and new-onset diabetes, has changed.
Journal ArticleDOI
Use and Perception of Telemedicine in People with Type 1 Diabetes During the COVID-19 Pandemic: A 1-Year Follow-Up
TL;DR: In this paper , the authors conducted a 1-year follow-up to investigate changes in opinions and experiences to telemedicine over the past year of the COVID-19 pandemic.
Journal ArticleDOI
ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes education in children and adolescents
Anna Lindholm Olinder,Matthew DeAbreu,Stephen J. Greene,Anne Haugstvedt,Karin Lange,Edna Majaliwa,Vanita Pais,Julie Pélicand,Marissa Town,Farid H. Mahmud +9 more
TL;DR: This book aims to provide a history of type one diabetes in adolescents and young people in the developing world through the lens of endocrinology, physiology and psychology.
Journal ArticleDOI
Telemedicine for the Clinical Management of Diabetes; Implications and Considerations After COVID-19 Experience
TL;DR: In this article , a review of telemedicine application in type 1 and type 2 diabetic individuals during the COVID-19 pandemic is presented, and future perspectives for tele-medical use to manage diabetes are discussed.
References
More filters
Journal ArticleDOI
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
Fei Zhou,Ting Yu,Ronghui Du,Guohui Fan,Ying Liu,Zhibo Liu,Jie Xiang,Yeming Wang,Bin Song,Xiaoying Gu,Xiaoying Gu,Lulu Guan,Yuan Wei,Li Hui,Xudong Wu,Jiuyang Xu,Shengjin Tu,Yi Zhang,Hua Chen,Bin Cao +19 more
TL;DR: Wang et al. as discussed by the authors used univariable and multivariable logistic regression methods to explore the risk factors associated with in-hospital death, including older age, high SOFA score and d-dimer greater than 1 μg/mL.
Journal ArticleDOI
Factors associated with COVID-19-related death using OpenSAFELY.
Elizabeth A. Williamson,Alex J Walker,Krishnan Bhaskaran,Seb Bacon,Chris Bates,Caroline E Morton,Helen J Curtis,Amir Mehrkar,David M. Evans,Peter Inglesby,Jonathan Cockburn,Helen Mcdonald,Brian MacKenna,Laurie A. Tomlinson,Ian J. Douglas,Christopher T Rentsch,Rohini Mathur,Angel Y S Wong,Richard Grieve,David G. Harrison,Harriet Forbes,Anna Schultze,Richard Croker,John Parry,Frank Hester,Sam Harper,Rafael Perera,Stephen J. W. Evans,Liam Smeeth,Ben Goldacre +29 more
TL;DR: A range of clinical factors associated with COVID-19-related death is quantified in one of the largest cohort studies on this topic so far and includes people of white ethnicity, Black and South Asian people were at higher risk, even after adjustment for other factors.
Journal ArticleDOI
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
Tadej Battelino,Thomas Danne,Richard M. Bergenstal,Stephanie A. Amiel,Roy W. Beck,Torben Biester,Emanuele Bosi,Bruce A. Buckingham,William T. Cefalu,Kelly L. Close,Claudio Cobelli,Eyal Dassau,J. Hans DeVries,Kim C. Donaghue,Klemen Dovc,Francis J. Doyle,Satish K. Garg,George Grunberger,Simon Heller,Lutz Heinemann,Irl B. Hirsch,Roman Hovorka,Weiping Jia,Olga Kordonouri,Boris Kovatchev,Aaron J. Kowalski,Lori M. Laffel,Brian J. Levine,Alexander Mayorov,Chantal Mathieu,Helen R. Murphy,Revital Nimri,Kirsten Nørgaard,Christopher G. Parkin,Eric Renard,David Rodbard,Banshi Saboo,Desmond A. Schatz,Keaton C. Stoner,Tatsuiko Urakami,Stuart A. Weinzimer,Moshe Phillip,Moshe Phillip +42 more
TL;DR: This article summarizes the ATTD consensus recommendations for relevant aspects of CGM data utilization and reporting among the various diabetes populations.
Journal ArticleDOI
International Consensus on Use of Continuous Glucose Monitoring
Thomas Danne,Revital Nimri,Tadej Battelino,Richard M. Bergenstal,Kelly L. Close,J. Hans DeVries,Satish K. Garg,Lutz Heinemann,Irl B. Hirsch,Stephanie A. Amiel,Roy W. Beck,Emanuele Bosi,Bruce A. Buckingham,Claudio Cobelli,Eyal Dassau,Francis J. Doyle,Simon Heller,Roman Hovorka,Weiping Jia,Timothy W. Jones,Olga Kordonouri,Boris P. Kovatchev,Aaron J. Kowalski,Lori M.B. Laffel,David M. Maahs,Helen R. Murphy,Kirsten Nørgaard,Christopher G. Parkin,Eric Renard,Banshi Saboo,Mauro Scharf,William V. Tamborlane,Stuart A. Weinzimer,Moshe Phillip +33 more
TL;DR: This article summarizes the ATTD consensus recommendations and represents the current understanding of how CGM results can affect outcomes.
Journal ArticleDOI
Coronavirus Disease 2019 Case Surveillance - United States, January 22-May 30, 2020.
Erin K. Stokes,Laura D. Zambrano,Kayla N. Anderson,Ellyn P. Marder,Kala M. Raz,Suad El Burai Felix,Yunfeng Tie,Kathleen E. Fullerton +7 more
TL;DR: The COVID-19 pandemic continues to be severe, particularly in certain population groups, and the need to build on current efforts to collect and analyze case data, especially among those with underlying health conditions is underscored.